Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in the prevalence of syphilis, a rising focus on vertical transmission prevention, and a rise in the adoption of POC testing devices.
The syphilis testing market is segmented as below:
By End-user
- Primary and secondary syphilis
- Latent
- tertiary syphilis
By Technology
- Laboratory testing/conventional testing
- POC testing
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the syphilis testing market covers the following areas:
- Syphilis testing market sizing
- Syphilis testing market forecast
- Syphilis testing market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
The publisher recognizes the following companies as the key players in the global syphilis testing market: Abbott Laboratories, AdvaCare Pharma, Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioLytical Laboratories Inc., Bloodworks Northwest, Calibre Scientific Inc., Danaher Corp., DiaSorin SpA, Everlywell Inc., F. Hoffmann La Roche Ltd., Hologic Inc., LetsGetChecked, Meril Life Sciences Pvt. Ltd., OK Biotech Co. Ltd., Omega Diagnostics Group Plc, OriGene Technologies Inc., Siemens Healthineers AG, and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is advancements in syphilis testing technologies.'
According to the report, one of the major drivers for this market is the increase in prevalence of syphilis.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- AdvaCare Pharma
- Beckman Coulter Inc.
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- bioLytical Laboratories Inc.
- Bloodworks Northwest
- Calibre Scientific Inc.
- Danaher Corp.
- DiaSorin SpA
- Everlywell Inc.
- F. Hoffmann La Roche Ltd.
- Hologic Inc.
- LetsGetChecked
- Meril Life Sciences Pvt. Ltd.
- OK Biotech Co. Ltd.
- Omega Diagnostics Group Plc
- OriGene Technologies Inc.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.